Dawaa Reference

chronic

Benign Neoplasm of the Ear

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Anatomy, Smooth Muscle - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK532857/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class HD25.00 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

A confirmed benign ear growth (such as an osteoma or benign skin lesion) still needs specialist assessment and possible removal; there is no GP-level drug treatment. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A confirmed benign ear growth (such as an osteoma or benign skin lesion) still needs specialist assessment and possible removal; there is no GP-level drug treatment.

Cautions
  • Rare in Egyptian primary care.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - A growth causing hearing loss or ear canal obstruction, or any change in size or appearance that suggests the lesion should be reclassified: assess and refer.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.